Latest News

Title
Prostate Cancer
02 May 2017 FDA Grants Accelerated Approval to Brigatinib and Breakthrough Therapy Designation to Lorlatinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
02 May 2017 ELCC 2017 Press Release: Men Need More Frequent Lung Cancer Screening Than Women Diagnosis, Imaging and Staging - Lung and other thoracic tumours
28 Apr 2017 FDA Expands Indications for Regorafenib Gastrointestinal cancers - Anticancer agents & Biologic therapy
28 Apr 2017 Annals of Oncology Press Release: England’s Cancer Drugs Fund ‘Failed to Deliver Meaningful Value to Patients and Society’ Bioethics, legal and economic issues
27 Apr 2017 New ESMO/ACF Patient Guide on Multiple Myeloma now Online
27 Apr 2017 EMA Recommends Approval of Two Biosimilar Medicines – Biosimilar Rituximab Haematologic malignancies - Anticancer agents & Biologic therapy
26 Apr 2017 EMA Recommends Granting a Marketing Authorisation for Inotuzumab Ozogamicin Haematologic malignancies - Anticancer agents & Biologic therapy
26 Apr 2017 ELCC 2017 Press Release: Annual Flu Jab May Pose Greater Risk for Lung Cancer Patients Under Immunotherapy Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
25 Apr 2017 EMA Recommends Extension of Indications for Bevacizumab Gynaecologic malignancies - Anticancer agents & Biologic therapy
25 Apr 2017 Professional Burnout in European Young Oncologists
24 Apr 2017 2017 edition of ESMO / ASCO Global Curriculum for Training in Medical Oncology Log Book is now available!
24 Apr 2017 EMA Recommends Extension of Indications for Nivolumab Genitourinary cancers - Cancer Immunology and Immunotherapy
21 Apr 2017 ELCC 2017 Press Release: Heine H. Hansen Award Given to Rafal Dziadziuszko